Download PDF
Semin Respir Crit Care Med 2020; 41(03): 354-359
DOI: 10.1055/s-0040-1710535
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Enhanced Recovery after Thoracic Surgery

Linda W. Martin
1   Thoracic Surgery, University of Virginia Health System, Charlottesville, Virginia
› Author Affiliations
Further Information

Publication History

Publication Date:
25 May 2020 (online)

    Permissions and Reprints

Abstract

Enhanced recovery programs (ERPs) aim to reduce psychological and physiological stress related to surgery, and minimize opioid use. This article describes the tenets of enhanced recovery, the guidelines for ERP in lung surgery, and the University of Virginia experience with developing and implementing a program. The impact of these strategies on short-term patient outcomes and potential long-term benefits including influence on lung cancer-specific outcomes are reviewed. The opioid crisis is of utmost importance; this article will explore how ERPs may be a mitigating factor.

Keywords

enhanced recovery - lung cancer surgery - opioid reduction - rib block - outcomes
 

  • References

  • 1 Krebs ED, Mehaffey JH, Sarosiek BM, Blank RS, Lau CL, Martin LW. Is less really more? Reexamining video-assisted thoracoscopic versus open lobectomy in the setting of an enhanced recovery protocol. J Thorac Cardiovasc Surg 2019; S0022-5223 (19) 31771-317714 . Doi: 10.1016/j.jtcvs.2019.08.036
    PubMedGoogle Scholar
  • 2 Modesitt SC, Sarosiek BM, Trowbridge ER. , et al. Enhanced recovery implementation in major gynecologic surgeries: effect of care standardization. Obstet Gynecol 2016; 128 (03) 457-466
    CrossrefPubMedGoogle Scholar
  • 3 Thiele RH, Rea KM, Turrentine FE. , et al. Standardization of care: impact of an enhanced recovery protocol on length of stay, complications, and direct costs after colorectal surgery. J Am Coll Surg 2015; 220 (04) 430-443
    CrossrefPubMedGoogle Scholar
  • 4 Moyse DW, Kaye AD, Diaz JH, Qadri MY, Lindsay D, Pyati S. Perioperative ketamine administration for thoracotomy pain. Pain Physician 2017; 20 (03) 173-184
    PubMedGoogle Scholar
  • 5 Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E. , et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg 2019; 55 (01) 91-115
    CrossrefPubMedGoogle Scholar
  • 6 Martin LW, Sarosiek BM, Harrison MA. , et al. Implementing a thoracic enhanced recovery program: lessons learned in the first year. Ann Thorac Surg 2018; 105 (06) 1597-1604
    CrossrefPubMedGoogle Scholar
  • 7 Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Task Force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. Anesthesiology 2017; 126 (03) 376-393
    CrossrefPubMedGoogle Scholar
  • 8 Sarin A, Chen LL, Wick EC. Enhanced recovery after surgery-preoperative fasting and glucose loading-a review. J Surg Oncol 2017; 116 (05) 578-582
    CrossrefPubMedGoogle Scholar
  • 9 Thiele RH, Raghunathan K, Brudney CS. , et al; Perioperative Quality Initiative (POQI) I Workgroup. American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Perioper Med (Lond) 2016; 5: 24
    CrossrefPubMedGoogle Scholar
  • 10 Smith MD, McCall J, Plank L, Herbison GP, Soop M, Nygren J. Preoperative carbohydrate treatment for enhancing recovery after elective surgery. Cochrane Database Syst Rev 2014; (08) CD009161
    PubMedGoogle Scholar
  • 11 Mehran RJ, Martin LW, Baker CM, Mena GE, Rice DC. Pain management in an enhanced recovery pathway after thoracic surgical procedures. Ann Thorac Surg 2016; 102 (06) e595-e596
    CrossrefPubMedGoogle Scholar
  • 12 Rice DC, Cata JP, Mena GE, Rodriguez-Restrepo A, Correa AM, Mehran RJ. Posterior intercostal nerve block with liposomal bupivacaine: an alternative to thoracic epidural analgesia. Ann Thorac Surg 2015; 99 (06) 1953-1960
    CrossrefPubMedGoogle Scholar
  • 13 Martin LW, Mehran RJ. Intercostal nerve blockade for thoracic surgery with liposomal bupivacaine: the devil is in the details. J Thorac Dis 2019; 11 (Suppl. 09) S1202-S1205
    CrossrefPubMedGoogle Scholar
  • 14 Cerfolio RJ, Bryant AS. Results of a prospective algorithm to remove chest tubes after pulmonary resection with high output. J Thorac Cardiovasc Surg 2008; 135 (02) 269-273
    CrossrefPubMedGoogle Scholar
  • 15 Brunelli A, Thomas C, Dinesh P, Lumb A. Enhanced recovery pathway versus standard care in patients undergoing video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg 2017; 154 (06) 2084-2090
    CrossrefPubMedGoogle Scholar
  • 16 Madani A, Fiore Jr JF, Wang Y. , et al. An enhanced recovery pathway reduces duration of stay and complications after open pulmonary lobectomy. Surgery 2015; 158 (04) 899-908 , discussion 908–910
    CrossrefPubMedGoogle Scholar
  • 17 Van Haren RM, Mehran RJ, Mena GE. , et al. Enhanced recovery decreases pulmonary and cardiac complications after thoracotomy for lung cancer. Ann Thorac Surg 2018; 106 (01) 272-279
    CrossrefPubMedGoogle Scholar
  • 18 Rogers LJ, Bleetman D, Messenger DE. , et al. The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer. J Thorac Cardiovasc Surg 2018; 155 (04) 1843-1852
    CrossrefPubMedGoogle Scholar
  • 19 Semenkovich TR, Hudson JL, Subramanian M, Kozower BD. Enhanced recovery after surgery (ERAS) in thoracic surgery. Semin Thorac Cardiovasc Surg 2018; 30 (03) 342-349
    CrossrefPubMedGoogle Scholar
  • 20 Medbery RL, Fernandez FG, Khullar OV. ERAS and patient reported outcomes in thoracic surgery: a review of current data. J Thorac Dis 2019; 11 (Suppl. 07) S976-S986
    CrossrefPubMedGoogle Scholar
  • 21 Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol 2014; 110 (02) 107-114
    CrossrefPubMedGoogle Scholar
  • 22 Nelson DB, Mehran RJ, Mitchell KG. , et al. Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer. J Thorac Cardiovasc Surg 2019; 158 (01) 279.e1-286.e1
    PubMedGoogle Scholar
  • 23 Petersen RP, Pham D, Burfeind WR. , et al. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 2007; 83 (04) 1245-1249 , discussion 1250
    CrossrefPubMedGoogle Scholar
  • 24 Licht PB, Jørgensen OD, Ladegaard L, Jakobsen E. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer. Ann Thorac Surg 2013; 96 (03) 943-949 , discussion 949–950
    CrossrefPubMedGoogle Scholar
  • 25 Medbery RL, Gillespie TW, Liu Y. , et al. Nodal upstaging is more common with thoracotomy than with VATS during lobectomy for early-stage lung cancer: an analysis from the national cancer data base. J Thorac Oncol 2016; 11 (02) 222-233
    CrossrefPubMedGoogle Scholar
  • 26 Merritt RE, Hoang CD, Shrager JB. Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer. Ann Thorac Surg 2013; 96 (04) 1171-1177
    CrossrefPubMedGoogle Scholar
  • 27 Brummett CM, Waljee JF, Goesling J. , et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg 2017; 152 (06) e170504
    CrossrefPubMedGoogle Scholar
  • 28 Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ 2014; 348: g1251
    PubMedGoogle Scholar
  • 29 Nelson DB. Niu J, Mitchell KG. , et al. Persistent opioid use among the elderly after lung resection: a SEER-Medicare study. Ann Thorac Surg 2020; 109 (01) 194-202
    CrossrefPubMedGoogle Scholar
  • 30 Brescia AA, Harrington CA, Mazurek AA. , et al. Factors associated with new persistent opioid usage after lung resection. Ann Thorac Surg 2019; 107 (02) 363-368
    CrossrefPubMedGoogle Scholar
  • 31 Lennon FE, Mirzapoiazova T, Mambetsariev B. , et al. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and epithelial mesenchymal transition (EMT) in human lung cancer. PLoS One 2014; 9 (03) e91577
    CrossrefPubMedGoogle Scholar
  • 32 Singleton PA, Mirzapoiazova T, Hasina R, Salgia R, Moss J. Increased μ-opioid receptor expression in metastatic lung cancer. Br J Anaesth 2014; 113 (Suppl. 01) i103-i108
    CrossrefPubMedGoogle Scholar
  • 33 Fujioka N, Nguyen J, Chen C. , et al. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg 2011; 113 (06) 1353-1364
    CrossrefPubMedGoogle Scholar
  • 34 Maher DP, Wong W, White PF. , et al. Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis. Br J Anaesth 2014; 113 (Suppl. 01) i88-i94
    CrossrefPubMedGoogle Scholar
  • 35 Nelson DB, Cata JP, Niu J. , et al. Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer. Pain 2019; 160 (10) 2365-2373
    CrossrefPubMedGoogle Scholar
  • 36 Lee L, Tran T, Mayo NE, Carli F, Feldman LS. What does it really mean to “recover” from an operation?. Surgery 2014; 155 (02) 211-216
    CrossrefPubMedGoogle Scholar